The study was conducted in South Korea on the alleged link between the use of ranitidine and cancer, which has concluded the debate on the alleged link between the use of ranitidine and the risk of cancer.
The move was taken after the company received multiple queries on the news item for recall of ranitidine by the drug firm.
Dr V G Somani, director of the Drug Controller General of India (DCGI) under the health ministry, has directed directorates of drug controls across states and UTs saying, “It has been reported from other countries that some ranitidine medicines contain nitrosamine impunity called N-nitrosodimethylamine (NDMA) at low levels.”
